— Know what they know.
Not Investment Advice
Also trades as: GLENMARK.BO (BSE) · $vol 1M

GLENMARK.NS NSE

Glenmark Pharmaceuticals Limited
1W: -4.1% 1M: -5.6% 3M: +5.4% YTD: +19.1% 1Y: +15.0% 3Y: +187.3% 5Y: +302.6%
₹2,326.10 ($24.17)
-4.90 (-0.21%)
 
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · ₹657.8B mcap · 142M float · 0.422% daily turnover

📊 Key Metrics

TTM
₹170B
Revenue
+27.8% YoY
₹14B
Net Income
+30.1% YoY
₹20B
Free Cash Flow
+260.4% YoY
41.5%
Gross Margin
16.3%
Op. Margin
8.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE14.1%
ROA7.6%
ROIC23.6%

Valuation

P/E36.6
P/B6.3
EV/EBITDA21.5

Leverage

Debt/Equity0.06
Current Ratio1.77
Interest Cov.10.5x

Quality Scores

Piotroski F8/9
Altman Z6.05
Beneish M-2.30

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms